Emergent Biosolutions Inc’s recent filing unveils that its Director DeGolyer Donald W unloaded Company’s shares for reported $0.27 million on Nov 12 ’24. In the deal valued at $10.91 per share,25,000 shares were sold. As a result of this transaction, DeGolyer Donald W now holds 111,100 shares worth roughly $0.8 million.
Then, White Marvin L sold 14,287 shares, generating $171,015 in total proceeds. Upon selling the shares at $11.97, the Director now owns 54,092 shares.
Before that, DeGolyer Donald W bought 25,000 shares. Emergent Biosolutions Inc shares valued at $294,250 were divested by the Director at a price of $11.77 per share.
H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of EBS
On Friday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock fall -7.13% to $7.16. Over the last five days, the stock has lost -26.34%. Emergent Biosolutions Inc shares have fallen nearly -25.10% since the year began. Nevertheless, the stocks have risen 164.21% over the past one year. While a 52-week high of $15.10 was reached on 01/24/25, a 52-week low of $1.82 was recorded on 02/24/25. SMA at 50 days reached $9.54, while 200 days put it at $8.65.
Levels Of Support And Resistance For EBS Stock
The 24-hour chart illustrates a support level at 6.91, which if violated will result in even more drops to 6.66. On the upside, there is a resistance level at 7.56. A further resistance level may holdings at 7.96. The Relative Strength Index (RSI) on the 14-day chart is 25.26, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.47%. Stochastics %K at 4.44% indicates the stock is a buying.
